Published in J Infect Dis on November 01, 2006
The use of Twitter to track levels of disease activity and public concern in the U.S. during the influenza A H1N1 pandemic. PLoS One (2011) 6.92
Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A (2012) 2.96
Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore. PLoS One (2010) 2.94
Influenza activity in Europe during eight seasons (1999-2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe. BMC Infect Dis (2007) 2.06
Innate immune control and regulation of influenza virus infections. J Leukoc Biol (2009) 1.92
Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007-2008. PLoS One (2009) 1.85
The burden of influenza in East and South-East Asia: a review of the English language literature. Influenza Other Respir Viruses (2008) 1.79
Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh, 2008-2010. Bull World Health Organ (2011) 1.74
Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis (2015) 1.62
Understanding influenza transmission, immunity and pandemic threats. Influenza Other Respir Viruses (2009) 1.60
Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. J Infect Dis (2012) 1.54
Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. BMC Infect Dis (2010) 1.53
Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors. Clin Infect Dis (2011) 1.52
Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza Other Respir Viruses (2009) 1.35
Use of hangeul twitter to track and predict human influenza infection. PLoS One (2013) 1.30
All-cause mortality during first wave of pandemic (H1N1) 2009, New South Wales, Australia, 2009. Emerg Infect Dis (2010) 1.22
Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice. Proc Natl Acad Sci U S A (2013) 1.22
Seasonal synchronization of influenza in the United States older adult population. PLoS One (2010) 1.18
Economic and social impact of influenza mitigation strategies by demographic class. Epidemics (2011) 1.13
Novel influenza virus NS1 antagonists block replication and restore innate immune function. J Virol (2008) 1.11
Optimizing influenza sentinel surveillance at the state level. Am J Epidemiol (2009) 1.11
Comparison of Xpert Flu rapid nucleic acid testing with rapid antigen testing for the diagnosis of influenza A and B. J Virol Methods (2012) 1.09
Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004. PLoS One (2011) 1.08
Influenza surveillance among outpatients and inpatients in Morocco, 1996-2009. PLoS One (2011) 1.05
The role of temperature and humidity on seasonal influenza in tropical areas: Guatemala, El Salvador and Panama, 2008-2013. PLoS One (2014) 1.05
Detection of excess influenza severity: associating respiratory hospitalization and mortality data with reports of influenza-like illness by primary care physicians. Am J Public Health (2010) 1.05
Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere. Eur J Clin Microbiol Infect Dis (2010) 1.05
A Simulation Optimization Approach to Epidemic Forecasting. PLoS One (2013) 1.04
A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge. Mol Ther (2010) 1.03
Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays. J Clin Microbiol (2010) 0.99
Seasonal oscillation of human infection with influenza A/H5N1 in Egypt and Indonesia. PLoS One (2011) 0.98
Burden of influenza-associated deaths in the Americas, 2002-2008. Influenza Other Respir Viruses (2015) 0.98
Comparison of a multiplex real-time PCR assay with a multiplex Luminex assay for influenza virus detection. J Clin Microbiol (2013) 0.97
Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation. PLoS One (2012) 0.97
Fish oil-fed mice have impaired resistance to influenza infection. J Nutr (2009) 0.96
Evaluating influenza disease burden during the 2008-2009 and 2009-2010 influenza seasons in Mongolia. Western Pac Surveill Response J (2011) 0.95
Estimates of excess medically attended acute respiratory infections in periods of seasonal and pandemic influenza in Germany from 2001/02 to 2010/11. PLoS One (2013) 0.94
Diagnosis of influenza from respiratory autopsy tissues: detection of virus by real-time reverse transcription-PCR in 222 cases. J Mol Diagn (2011) 0.91
Mortality burden of the 2009-10 influenza pandemic in the United States: improving the timeliness of influenza severity estimates using inpatient mortality records. Influenza Other Respir Viruses (2013) 0.91
Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses. J Virol (2015) 0.90
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A. PLoS One (2013) 0.89
Mortality associated with influenza in tropics, state of são paulo, Brazil, from 2002 to 2011: the pre-pandemic, pandemic, and post-pandemic periods. Influenza Res Treat (2013) 0.88
Modeling the airborne survival of influenza virus in a residential setting: the impacts of home humidification. Environ Health (2010) 0.88
Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response. J Virol (2013) 0.86
Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign. Vaccine (2010) 0.85
Situational awareness of influenza activity based on multiple streams of surveillance data using multivariate dynamic linear model. PLoS One (2012) 0.85
Disproportional effects in populations of concern for pandemic influenza: insights from seasonal epidemics in Wisconsin, 1967-2004. Influenza Other Respir Viruses (2010) 0.84
The population impact of a large school-based influenza vaccination campaign. PLoS One (2010) 0.84
Examining Perceptions about Mandatory Influenza Vaccination of Healthcare Workers through Online Comments on News Stories. PLoS One (2015) 0.83
Memory CD4 T cells in influenza. Curr Top Microbiol Immunol (2015) 0.83
Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge. Gene Ther (2015) 0.82
Trends in pneumonia and influenza-associated hospitalizations in South Korea, 2002-2005. J Health Popul Nutr (2011) 0.81
Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus. Mol Ther (2012) 0.81
Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia. PLoS One (2013) 0.80
Epidemiology and impact of influenza in Mongolia, 2007-2012. Influenza Other Respir Viruses (2014) 0.80
Deviations in influenza seasonality: odd coincidence or obscure consequence? Clin Microbiol Infect (2012) 0.80
Validation of a Pediatric Primary Care Network in a US Metropolitan Region as a Community-Based Infectious Disease Surveillance System. Interdiscip Perspect Infect Dis (2011) 0.79
Enhancement of influenza surveillance with aggregate rapid influenza test results: New Mexico, 2003-2007. Am J Public Health (2008) 0.78
Structural Basis for a Novel Interaction between the NS1 Protein Derived from the 1918 Influenza Virus and RIG-I. Structure (2015) 0.78
g-FLUA2H: a web-based application to study the dynamics of animal-to-human mutation transmission for influenza viruses. BMC Med Genomics (2015) 0.78
Impact of heat waves on nonaccidental deaths in Jinan, China, and associated risk factors. Int J Biometeorol (2016) 0.78
Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection. J Virol (2016) 0.78
Contribution of influenza viruses to medically attended acute respiratory illnesses in children in high-income countries: a meta-analysis. Influenza Other Respir Viruses (2016) 0.78
Medical and economic burden of influenza in the elderly population in central and eastern European countries. Hum Vaccin Immunother (2013) 0.78
Detecting signals of seasonal influenza severity through age dynamics. BMC Infect Dis (2015) 0.77
Pediatric influenza-associated deaths in new york state: death certificate coding and comparison to laboratory-confirmed deaths. Influenza Res Treat (2012) 0.77
Disease Surveillance on Complex Social Networks. PLoS Comput Biol (2016) 0.77
A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic review. BMC Infect Dis (2015) 0.76
In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential. Biomed Res Int (2015) 0.76
Pneumonia and influenza hospitalization in HIV-positive seniors. Epidemiol Infect (2010) 0.76
Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection. PLoS One (2013) 0.76
A Bayesian Outbreak Detection Method for Influenza-Like Illness. Biomed Res Int (2015) 0.75
Hemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 Infection. Mol Ther Nucleic Acids (2016) 0.75
Recognizing flu-like symptoms from videos. BMC Bioinformatics (2014) 0.75
Clinical differences of influenza subspecies among hospitalized children. Turk Pediatri Ars (2017) 0.75
The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses. Antimicrob Agents Chemother (2017) 0.75
Action Tweets Linked to Reduced County-Level HIV Prevalence in the United States: Online Messages and Structural Determinants. AIDS Behav (2016) 0.75
Human temperatures for syndromic surveillance in the emergency department: data from the autumn wave of the 2009 swine flu (H1N1) pandemic and a seasonal influenza outbreak. BMC Emerg Med (2016) 0.75
Alveolar Macrophages Prevent Lethal Influenza Pneumonia By Inhibiting Infection Of Type-1 Alveolar Epithelial Cells. PLoS Pathog (2017) 0.75
Recombinant adenoviruses displaying matrix 2 ectodomain epitopes (M2e) on their fiber proteins as universal influenza vaccines. J Virol (2017) 0.75
Synthetic TLR4 and TLR7 ligands work additively via MyD88 to induce protective antiviral immunity in mice. J Virol (2017) 0.75
Bayesian nonparametric clustering in phylogenetics: modeling antigenic evolution in influenza. Stat Med (2017) 0.75
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep (2008) 9.02
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA (2006) 8.06
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis (2012) 8.02
Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83
Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA (2005) 5.84
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 5.80
Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med (2003) 5.60
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32
Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 5.19
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16
Influenza vaccine effectiveness in the community and the household. Clin Infect Dis (2013) 3.40
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis (2012) 3.35
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol (2007) 3.33
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis (2009) 3.26
Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis (2010) 3.02
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis (2013) 3.00
The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis (2004) 2.96
Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis (2012) 2.91
The burden of influenza-associated critical illness hospitalizations. Crit Care Med (2014) 2.84
Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Viruses (2009) 2.82
Household responses to school closure resulting from outbreak of influenza B, North Carolina. Emerg Infect Dis (2008) 2.74
Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA (2010) 2.48
Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J Infect Dis (2006) 2.41
Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics (2008) 2.29
Influenza- and RSV-associated hospitalizations among adults. Vaccine (2006) 2.23
Monitoring influenza activity in the United States: a comparison of traditional surveillance systems with Google Flu Trends. PLoS One (2011) 2.21
Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics (2004) 2.08
Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season. J Infect Dis (2013) 2.07
Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. Pediatrics (2003) 2.03
Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One (2011) 1.94
Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med (2010) 1.83
The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine (2013) 1.79
Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clin Infect Dis (2010) 1.76
Estimating influenza-associated deaths in the United States. Am J Public Health (2009) 1.73
Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine (2009) 1.71
Innate immune function and mortality in critically ill children with influenza: a multicenter study. Crit Care Med (2013) 1.71
Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ (2012) 1.69
Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011. PLoS One (2013) 1.64
Effectiveness of interventions to reduce contact rates during a simulated influenza pandemic. Emerg Infect Dis (2007) 1.59
Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003-2004. Pediatr Infect Dis J (2006) 1.59
Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med (2003) 1.48
Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine (2011) 1.38
Influenza vaccination for elderly people and their care workers. Lancet (2006) 1.38
Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology (2005) 1.35
Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J (2003) 1.35
Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA (2006) 1.26
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population. Aging Dis (2011) 1.23
Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008. Influenza Other Respir Viruses (2011) 1.22
Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination. Clin Infect Dis (2011) 1.20
Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay. J Clin Microbiol (2002) 1.19
Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis (2013) 1.18
Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA. J Clin Microbiol (2003) 1.16
Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China. Influenza Other Respir Viruses (2013) 1.15
Performance evaluation of the VERSANT HCV RNA qualitative assay by using transcription-mediated amplification. J Clin Microbiol (2003) 1.11
Oseltamivir prescribing in pharmacy-benefits database, United States, 2004-2005. Emerg Infect Dis (2008) 1.10
Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness. J Infect Dis (2006) 1.05
Emergency department visits for influenza A(H1N1)pdm09, Davidson County, Tennessee, USA. Emerg Infect Dis (2012) 1.02
Time-series analyses of count data to estimate the burden of seasonal infectious diseases. Epidemiology (2012) 1.02
Evaluation of the core antigen assay as a second-line supplemental test for diagnosis of active hepatitis C virus infection. J Clin Microbiol (2004) 1.00
Improving immunogenicity and effectiveness of influenza vaccine in older adults. Expert Rev Vaccines (2011) 0.99
A national survey of the Infectious Diseases Society of America Emerging Infections Network concerning neuraminidase inhibitor prescription practices and pandemic influenza preparations. Clin Infect Dis (2006) 0.97
The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel. Vaccine (2012) 0.96
Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010. Influenza Other Respir Viruses (2012) 0.96
Outpatient and hospital visits associated with otitis media among American Indian and Alaska native children younger than 5 years. Pediatrics (2002) 0.94
A pilot study of host genetic variants associated with influenza-associated deaths among children and young adults. Emerg Infect Dis (2011) 0.93
Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol (2013) 0.93
Estimating age-specific influenza-related hospitalization rates during the pandemic (H1N1) 2009 in Davidson Co, TN. Influenza Other Respir Viruses (2012) 0.93
Diagnostic performance of the BinaxNow Influenza A&B rapid antigen test in ED patients. Am J Emerg Med (2012) 0.92
Inactivated influenza vaccines for prevention of community-acquired pneumonia: the limits of using nonspecific outcomes in vaccine effectiveness studies. Epidemiology (2013) 0.90
Comparison of nasal and nasopharyngeal swabs for influenza detection in adults. Clin Med Res (2012) 0.90
Use of rapid tests and antiviral medications for influenza among primary care providers in the United States. Influenza Other Respir Viruses (2009) 0.90
Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old. Vaccine (2013) 0.89
Attitudes of healthcare workers in U.S. hospitals regarding smallpox vaccination. BMC Public Health (2003) 0.88
Population-based incidence estimates of influenza-associated respiratory failure hospitalizations, 2003 to 2009. Am J Respir Crit Care Med (2013) 0.88
Estimates of the impact of a future influenza pandemic in China. Influenza Other Respir Viruses (2009) 0.88
Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine. J Infect Dis (2012) 0.87
Influenza and malaria coinfection among young children in western Kenya, 2009-2011. J Infect Dis (2012) 0.86
Evaluation of obesity as an independent risk factor for medically attended laboratory-confirmed influenza. Influenza Other Respir Viruses (2012) 0.85
Adamantane-resistant influenza infection during the 2004-05 season. Emerg Infect Dis (2008) 0.84
The Pregnancy and Influenza Project: design of an observational case-cohort study to evaluate influenza burden and vaccine effectiveness among pregnant women and their infants. Am J Obstet Gynecol (2011) 0.84
Incidence of influenza-associated mortality and hospitalizations in Argentina during 2002-2009. Influenza Other Respir Viruses (2012) 0.83
A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates. J Infect Dis (2012) 0.82
Influenza vaccination among the elderly in the United States. Arch Intern Med (2005) 0.81
Influenza vaccine for community-acquired pneumonia. Lancet (2008) 0.81
Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population. Vaccine (2005) 0.80
Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine. Vaccine (2012) 0.80
Household economic impact and attitudes toward school closures in two cities in Argentina during the 2009 influenza A (H1N1) pandemic. Influenza Other Respir Viruses (2012) 0.79
Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center. J Clin Virol (2004) 0.79
Trends in mortality from respiratory disease in Latin America since 1998 and the impact of the 2009 influenza pandemic. Bull World Health Organ (2013) 0.78
Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine (2005) 0.78
Reply to Fedson. J Infect Dis (2013) 0.77
Child, household, and caregiver characteristics associated with hospitalization for influenza among children 6-59 months of age: an emerging infections program study. Pediatr Infect Dis J (2014) 0.77
Influenza vaccination status is not associated with influenza testing among children: implications for observational studies of vaccine effectiveness. Vaccine (2011) 0.77